Latest Connectivity News

The Takeovers Panel has declined to investigate allegations against Duxton Farms’ major shareholders concerning a recent merger and capital placement, affirming no change in control despite reduced voting power.

Brazilian Rare Earths Limited (ASX – BRE) has announced a maiden JORC-compliant Mineral Resource Estimate for its Amargosa Bauxite-Gallium Project in Bahia, Brazil, revealing a substantial deposit with high-quality bauxite and significant gallium content.

Kelsian Group has postponed the start of its new Kangaroo Island ferry service to June 2026, citing vessel delivery delays and aiming to avoid peak season disruptions. The new ferries will significantly increase capacity and offer fare discounts to residents during the transition.

DigiCo Infrastructure REIT has secured new customers boosting Australian contracted IT capacity to 41MW by mid-2026, prompting an upward revision of its FY26 earnings guidance and accelerated development plans at its flagship SYD1 data centre.

Caravel Minerals has taken a major step forward by securing a preliminary grid connection offer from Western Power, paving the way for reliable, low-cost power at its Caravel Copper Project.

Dexus Industria REIT has acquired two fully leased industrial warehouses in Melbourne’s Dandenong South for $47.5 million, reinforcing its strategic focus on industrial assets and maintaining its FY26 financial guidance.

Nationwide Building Society has confirmed it has largely complied with its post-offer intentions following its acquisition of Virgin Money UK PLC, with a previously disclosed exception.

Cryosite Limited has inked a deal to acquire a strategic freehold warehouse in Auburn, NSW, doubling its storage capacity and positioning itself for significant growth in clinical trial logistics.

Connected Minerals has completed its Phase 2 reverse circulation drilling at the Ondapanda Prospect in Namibia, following strong initial results. The company anticipates assay results in three weeks that could further define its uranium potential.

Memphasys Limited has revised its FY25 financials to reflect a $1.12 million liability linked to uncertain compliance with R&D tax incentive rules, pending a private tax ruling.

Paradigm Biopharmaceuticals has dosed participants in its pivotal Phase 3 trial for knee osteoarthritis across the US and Australia, progressing steadily towards a mid-2026 interim analysis.

Amplitude Energy has launched the retail component of its fully underwritten entitlement offer, aiming to raise approximately A$20 million to support key growth projects including the expansion of the East Coast Supply Project and the potential restart of Patricia Baleen.